Concepedia

Publication | Closed Access

An experience with estrogen replacement therapy in breast cancer survivors.

21

Citations

0

References

1999

Year

Wendy R. Brewster, Philip J. DiSaia, Elizabeth A. Grosen, Kathleen F. McGonigle, Julie L. Kuykendall, William T. Creasman
PubMed

Abstract

The concern that ERT might activate growth in occult metastatic sites and promote a rash of recurrences was not confirmed. It is unreasonable to categorically deny all breast cancer survivors ERT.